Skip to content

PSYCHEMEDICS CORPORATION: 10-Q filed 2013-10-30

What PSYCHEMEDICS CORPORATION reported in its quarterly report filed 2013-10-30 (fiscal Q3 2013): 35 published measures, 96 facts as tagged in accession 0001144204-13-057560.

This filing

Form
10-Q (quarterly report)
Filed
2013-10-30
Fiscal period
fiscal Q3 2013
Accession
0001144204-13-057560 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PSYCHEMEDICS CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-09-3015,064,139USD
At 2012-12-3114,120,618USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-09-302,990,157USD
At 2012-12-312,897,949USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-09-3012,073,982USD
At 2012-12-3111,222,669USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-09-302,842,741USD
At 2012-12-313,065,785USD
At 2012-09-303,663,499USD
At 2011-12-315,564,233USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-301,052,000USD92
2013-01-01 to 2013-09-302,937,271USD273
2012-07-01 to 2012-09-30878,481USD92
2012-01-01 to 2012-09-302,707,016USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-09-303,852,525USD273
2012-01-01 to 2012-09-302,478,644USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-09-30835,735USD273
2012-01-01 to 2012-09-301,180,786USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-2,472,255USD273
2012-01-01 to 2012-09-30-2,460,289USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-1,603,314USD273
2012-01-01 to 2012-09-30-1,919,089USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-09-30-6,630,583USD
At 2012-12-31-7,186,009USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-07-01 to 2013-09-305,312,105shares92
2013-01-01 to 2013-09-305,301,330shares273
2012-07-01 to 2012-09-305,272,428shares92
2012-01-01 to 2012-09-305,256,240shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2013-07-01 to 2013-09-305,330,515shares92
2013-01-01 to 2013-09-305,314,224shares273
2012-07-01 to 2012-09-305,289,808shares92
2012-01-01 to 2012-09-305,266,237shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2013-07-01 to 2013-09-300.2USD/shares92
2013-01-01 to 2013-09-300.55USD/shares273
2012-07-01 to 2012-09-300.17USD/shares92
2012-01-01 to 2012-09-300.52USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2013-07-01 to 2013-09-300.2USD/shares92
2013-01-01 to 2013-09-300.55USD/shares273
2012-07-01 to 2012-09-300.17USD/shares92
2012-01-01 to 2012-09-300.51USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-07-01 to 2013-09-30687,579USD92
2013-01-01 to 2013-09-301,827,932USD273
2012-07-01 to 2012-09-30552,920USD92
2012-01-01 to 2012-09-301,766,336USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-09-304,954,481USD
At 2012-12-314,201,409USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-09-30386,297USD273
2012-01-01 to 2012-09-30337,078USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-09-301,739,299USD92
2013-01-01 to 2013-09-304,673,210USD273
2012-07-01 to 2012-09-301,430,954USD92
2012-01-01 to 2012-09-304,471,910USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-09-309,556,703USD
At 2012-12-319,573,916USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-09-302,175,538USD
At 2012-12-312,083,330USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-09-30577,081USD
At 2012-12-31669,789USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-09-305,293,505USD
At 2012-12-314,620,768USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-07-01 to 2013-09-302,436,753USD92
2013-01-01 to 2013-09-307,069,062USD273
2012-07-01 to 2012-09-302,286,749USD92
2012-01-01 to 2012-09-307,014,299USD274

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-07-01 to 2013-09-304,176,052USD92
2013-01-01 to 2013-09-3011,742,272USD273
2012-07-01 to 2012-09-303,717,703USD92
2012-01-01 to 2012-09-3011,486,209USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-07-01 to 2013-09-30203,265USD92
2013-01-01 to 2013-09-30558,011USD273
2012-07-01 to 2012-09-30297,090USD92
2012-01-01 to 2012-09-30679,031USD274

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-09-305,018,365USD
At 2012-12-314,395,605USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-09-30552,955USD
At 2012-12-31345,293USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-09-301,598,457USD
At 2012-12-311,413,541USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2013-09-301,055,363USD
At 2012-12-31823,274USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2013-07-01 to 2013-09-301,739,579USD92
2013-01-01 to 2013-09-304,765,203USD273
2012-07-01 to 2012-09-301,431,401USD92
2012-01-01 to 2012-09-304,473,352USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-301,075,133USD92
2013-01-01 to 2013-09-303,075,794USD273
2012-07-01 to 2012-09-30921,891USD92
2012-01-01 to 2012-09-302,921,880USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-01-01 to 2013-09-30642,580USD273
2012-01-01 to 2012-09-30419,541USD274

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-155,217USD273
2012-01-01 to 2012-09-30-136,180USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30672,737USD273
2012-01-01 to 2012-09-30852,362USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-92,708USD273
2012-01-01 to 2012-09-30304,759USD274

Inspect the source

Entity
PSYCHEMEDICS CORPORATION / CIK 0000806517
Captured
2026-09-21T17:17:03.097Z
SEC response SHA-256
86f20b52a099e76620fe6881a053ed61515c47925a0b1b6a4ed64f7b833f6a17

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000806517.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))